BEIJING (Sputnik) – China’s National Medical Products Administration authorized on Thursday the public use of the Sinopharm vaccine against the coronavirus, the China Central Television reported.
On Wednesday, Sinopharm’s subsidiary Beijing Institute of Biological Products said that the efficiency of its vaccine had exceeded 79 percent. The vaccine has already been approved by Bahrain and the United Arab Emirates.
The scientists will reportedly continue to study the efficiency of the vaccine.
In this April 11, 2020, photo released by Xinhua News Agency, a staff member tests samples of a potential COVID-19 vaccine at a production plant of SinoPharm in Beijing.
According to earlier statements of Sinopharm, about 1 million people have already been vaccinated with its drug, including 60,000 people outside China.
Sourse: sputniknews.com
0.00 (0%) 0 votes
MOSCOW (Sputnik) - The Coalition for the Restoration of Democracy (CORED), which unites 18 opposition parties in Guinea, said on…
The news of an interplanetary scale comes after NASA believed it had captured its first sample with Perseverance last month,…
MOSCOW (Sputnik) - The last pipe of the second string of Nord Stream 2 has been welded, and after a…
LONDON (Sputnik) – The UK government on Monday condemned the military coup against the president of Guinea, Alpha Conde, and…